Ringhoffer, M <br/><br/>
[Systemic therapy of metastatic renal cell carcinoma: from many options to the therapeutic strategy].  [electronic resource] 

 -  Der Urologe. Ausg. A  Nov 2009 
 - 1308-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1433-0563 
<br/><br/><label>Standard No.: </label>10.1007/s00120-009-2109-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Algorithms<br/>Antibodies, Monoclonal--therapeutic use<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Renal Cell--drug therapy<br/>Disease Progression<br/>Humans<br/>Interferon-alpha--adverse effects<br/>Interleukin-2--adverse effects<br/>Intracellular Signaling Peptides and Proteins--antagonists & inhibitors<br/>Neoplasm Staging<br/>Practice Guidelines as Topic<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>TOR Serine-Threonine Kinases